Drugs Affecting Blood - PowerPoint PPT Presentation

1 / 44
About This Presentation
Title:

Drugs Affecting Blood

Description:

Drugs Affecting Blood Thrombosis Platelet inhibitor Anticoagulants Thrombolytic agents Treatment of Bleeding – PowerPoint PPT presentation

Number of Views:99
Avg rating:3.0/5.0
Slides: 45
Provided by: llh8
Category:

less

Transcript and Presenter's Notes

Title: Drugs Affecting Blood


1
  • ?????????????
  • Drugs Affecting Blood
  • Thrombosis
  • Platelet inhibitor
  • Anticoagulants
  • Thrombolytic agents
  • Treatment of Bleeding
  • Treatment of Anemia

2
????
  • ???????????????
  • ???????????????(?????????????)????????????????????
    ??
  • ?????????????
  • ??????????????B12??????????????

3
Hemostasis
  • ??
  • ?????????????

??????? ??????????????
  • ????

???Protein C S Va, VIIIa, Xa AT-III IIa, IXa,
Xa, XIa, XIIa
4
???????(Intrinsic)
???????(Extrinsic)
???AT-??????
?????????
5
  • ???? Thrombosis
  • ?????????????,??????
  • ?????????????????????
  • ????????
  • ??????,???????????????????
  • ???????????????????
  • ??????

?????---????---???????????
6
Formation of a hemostatic plug
1
Damage to vessel expose collagen to subendothelium
Prothrombin (II)

2
Thrombin (IIa)
Platelet adhesion and release of granules
2
3
Fibrinogen(I)
Fibrin
Activation of coagulation factors in plasma
1
4
Chemical mediators Released by platelets
Platelets cover and adhere to exposed
subendothelial surface
Platelet aggregation and formation of fibrin plug
3
7
(No Transcript)
8
TXA2 binds to receptors on other platelets
thereby initiating release of additional
aggregating agents.
5-HT ADP
Balance between levels of PGI2 and TXA2
influences whether platelet aggregates or
circulates freely
Platelet
TXA2
PGG2, PGH2
Granules
DAG IP3
Aspirin
cAMP
ATP
AA
Dipyridamole
  • Healthy, intact endothelium releases PGI2 into
    plasma.
  • PGI2 binds to platelet membrane receptors causing
    synthesis of cAMP.
  • cAMP inhibits release of granules containing
    aggregating agents.

5-AMP
  • Thrombin, TXA2 and exposed collagen cause release
    of AA from platelet membrane.
  • TXA2 is synthesized from AA and released from the
    platelet.
  • This pathway is inhibited by aspirin.

PGI2
TXA2
Endothelial cells
Collagen fibers
9
????
????? ????
??? ??
ATP
AC
ADP
cAMP
????? ????
?????
??

IIa
PLA2
?????
?????
????
??
COX
????
???
PGG2 PGH2
TXA2
PGI2
XIIa,Ka,???? SK,UK,t-PA
????
????
10
  • ???(Antithrombotic drugs)

??????(Anticoagulants)
????????? (Fibrinolytics)
???????(Antiplatelet drugs)
11
  • ???(antithrombotic drugs)

??????(Anticoagulants)
  • ?? Heparin
  • ??? Hirudin
  • ???? Coumarin

????????? (Fibrinolytics)
  • ??? Streptokinase
  • ??? Urokinase
  • ????????????? t-pA,
  • (Human tissue-type plasminogen activator)

12
? ???? (Anticoagulants)
?? (Heparin) ???????
???????,?????(??????)?
?????????(??,????)?
?????????,???????????
??????????????
13
Sensitivity of coagulation screening tests to
factor deficiency
14
Fig. Effects of TET and FAN on the human plasma
coagulation time.
  • ????????? activated partial thromboplastin time
    (APTT) ??????.Cephaline CaCl2
  • ????? prothrombin time (PT) ??????.Calcium-thromb
    oplastin
  • ????? thrombin time (TT) ????????Thrombin

15
???????????AT-III
??AT-???? (???????a??a??a??a??a?Ka????). ??-AT-?-?
??????(???????).
?????? (LMWH)Low Molecular Weight Heparin
  • 1????AT-III???????a?
  • 2?T ½ gt heparin
  • 3????heparin,??????????.

??????
16
  • No Heparin
  • With Heparin

Active clotting factors (IIa, IXa, Xa, XIIa,
XIIIa) (Serine residue)
Active clotting factors (IIa, IXa, Xa, XIIa,
XIIIa) (Serine residue)
Antithrombin III (arginine-residue)
Rapid
Slow
Inactive factors
Inactive factors
17
? ???? (Anticoagulants)
?????? ????(Coumarin) ???(Warfarin)
????
?????K???,??????????????????????C?S??-????????????
???,???????
??!
18
Coumarin
Warfarin
Dicoumarin
O2
V-k
19
(No Transcript)
20
????????? ???????
??????
  • ??????????????????4??
  • ??????1?2??????,??????????
  • ??? Prothrombin time (PTT)

21
????????
????????????? 1)?????,????????????
2)????????????????K 3)????,????????
???????????????????(?????????) ????,????,????
22
? ??????? Fibrinolytics
???(Streptokinase,SK)
???????
??????????? ? ?????? ? ?????
?????????????(????)?
?????
?????,????,?????,???????,?????????
23
? ??????? Fibrinolytics
??? (urokinase)
???????
??????? ????????,??????????????????????
?????????? (human tissue-type plasminogen
activator,t-pA)
??????
???????????????????????????
24
????
????????????
???
???
?????????
????????
?????
????
????????????????????
25
  • ???? Coagulants

???K ?? Human plasma VIII ??? ????
Cryoprecipitate ??? Thrombin ???????
Desmopressin acetate ???? Aminomethylbenzoic
acid, PAMBA ???? Tranexamic acid, AMCHA, ???
26
????
????????????
???
???
?????????
????????
?????
????
????????????????????
27
  • ???(Antithrombotic drugs)

???????(Antiplatelet drugs)
  • ??????????
  • ??????cAMP???????(???)
  • ??ADP??????GPIIb/IIIa??????
  • ???? Ticlopidine (????)
  • ?????????
  • ????GP IIb/IIIa?????????
  • ???? PGI2

28
(No Transcript)
29
(No Transcript)
30
(No Transcript)
31
? ???? (Aspirin) ??????
??
???(40 -80 mg/?) ??????COX?TXA2?
????????,??????? ????(300 mg/?) ?????
??????????COX? PGI2 ??? ???????? ?
??
1)?????????????
32
  • Effect of aspirin on AA pathway

AA

COX
AcO-
PGG2
AcO-COX Inactive
TXA2
33
FDA ?EMEA ?????????? ????????( celecoxib ,
???,Celebrex)????????(CV)????(GI)???????????? ????
???? ??FDA COX-2????????????????? ??EMEA
?????????????????COX-2???,????????,???????????????
?????????????COX-2????????
34
  • ?????????8?21???,????????????????????????6???
    ????????8?19?,??????????????????????????2.53????
    ????,??????????2001?5?????????

35
(No Transcript)
36
  • ??????cAMP???

???? (dipyridamole ,???persantin)
??????
???????(???????????)?
  • ??PDE?cAMP?????????
  • ??PGI2??,?????
  • ???????AC ?cAMP?
  • ???????COX ? TXA2?

????
???????????
37
(No Transcript)
38
? ??ADP????????
????(Ticlid)
????
???????,????????
????
??????
ADP????GPIIb/IIIa(receptor)?? ? ?????(ligand)?? ?
??????
39
(No Transcript)
40
? ???GP IIb/IIIa?????
???? Abciximab (????) (GP IIb/IIIa??????)
????
??GP IIb/IIIa?? ? ????????????? ?????????
???(Hirudin) ?????????(IIa)???? ??????????PTCA????
?????
41
Plaque Disruption
Collagen
vWF
Platelet Adhision and Activation
Aspirin
Procoagulant Activity
?
TXA2
ADP
Thrombin
Thrombin Inhibitors
Ticlopidine Clopidogrel
?
?
Conformational Activation of GPIIb/IIIa
GPIIb/IIIa Antagonists
?
Platelet Aggregation
42
Sites where common antiplatelet drug therapies
work
43
  • ??????????

????????
?????? Erythropoitin (EPO) ????? Stem cell
factor(SCF) ??? 112 Interleukins
(IL-112) ???-?????????? Granulocyte-macrophage
colony stimulating factor (GM-CSF) ?????????
Granulocyte colony stimulating factor
(G-CSF) ????-?????????? Monocyte-macrophage
colony stimulating factor (M-CSF)
44
  • ???? Antianemia drugs

??
???Ferrous sulfate?Iron dextran?
Ferric ammonium citrate ??? Folic acid ???B12
  • ??????

???? Dextran70?40?20?10 ???
Write a Comment
User Comments (0)
About PowerShow.com